GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior
Sign Up to like & getrecommendations! Published in 2022 at "Diabetes"
DOI: 10.2337/db21-0848
Abstract: The induction of nausea and emesis is a major barrier to maximizing the weight loss profile of obesity medications, and therefore, identifying mechanisms that improve tolerability could result in added therapeutic benefit. The development of… read more here.
Keywords: gipr agonism; induced nausea; nausea; pyy induced ... See more keywords